The significance of Focal C4d+: The WU experience Helen Liapis, M.D. Professor of Pathology & immunology Kedainis RL et al. Am J Transplant. 2009 Apr;9(4):812-9.

Slides:



Advertisements
Similar presentations
PRA = 36% (21/58) Anti-A11 and B44.
Advertisements

Michael Mengel Department of Laboratory Medicine and Pathology
Kidney allografts with biopsy features of chronic mixed rejection reflect poorer survival than those with pure chronic antibody-mediated rejection D. Dobi,
Therapeutic Penetrating Keratoplasty in Fungal Keratitis: Prospective Study Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Efficacy and Safety of Three Bortezomib-Based Combinations in Elderly, Newly Diagnosed Multiple Myeloma Patients: Results from All Randomized Patients.
The Value of Zero-Hour Implantation Biopsies Volker Nickeleit Nephropathology Laboratory, Department of Pathology The University of North Carolina, Chapel.
Role of recurrent disease for late allograft loss Fernando G. Cosio Mayo Clinic, Rochester MN 10 th Banff conference on allograft pathology.
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.
POLYOMAVIRUS INFECTION IN RENAL ALLOGRAFTS: PROGRESS SINCE BANFF 1999 Parmjeet Randhawa Associate Professor Division of Transplantation Pathology Department.
C4d – The Birmingham UK Experience Desley Neil, Majid Mukadam, David Briggs* UHBNHSFT, NHSBT* Birmingham.
Donor Organ Selection Criteria: What is Ideal? A Consensus (?) Discussion.
GRADING OF REJECTION IN PANCREAS ALLOGRAFTS Are changes needed? Cinthia B. Drachenberg, M.D. University of Maryland School of Medicine Baltimore MD.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
Sum Scores and Scores of Individual Components in Clinical Practice and Clinical Trials Lillian W. Gaber University of Tennessee.
BACKGROUND ON PANCREAS HISTOLOGICAL FINDINGS: University of Maryland experience John C. Papadimitriou, M.D.,Ph.D. Professor of Pathology.
C4d - staining: Comparison of methods C. Seemayer, A. Gaspert, M. Mihatsch.
Short-term Benefits of Endometrial Biopsy are Similar to Diagnostic Laparoscopy for Unexplained Infertility Paul B. Miller, MD 1, Lauren M. O’Donnell 2,
ESRD Prognosis ERA-EDTA vs. Danish Renal Registry James Heaf.
Agnieszka Perkowska-Ptasinska1, M. Ciszek, A.L. Urbanowicz, L. Paczek,
Monitoring HLA-specific antibodies
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo.
Study of cytokine gene polymorphism and graft outcome in live-donor kidney transplantation By Rashad Hassan MD Amgad El-Agroudy, Ahmad Hamdy, Amani Mostafa.
Severe vascular lesions and poor functional outcome
Interactive Case Discussion Case 6 Dr Megha S Uppin Asst Prof Dept of Pathology Nizam’s Institute of Medical Sciences Hyderabad.
Kidney transplant case Niels Marcussen Hans Dieperink Odense University Hospital.
Outcome of therapeutic keratoplasty in fungal keratitis Sonika Gupta, MS Assistant Professor, GMCH, Chandigarh, India Author has no financial interest.
The Expanded Criteria Donors in Kidney Transplantation: 3 Years Experience FAM Shaheen, B. Al-Attar, MZ Souqiyyeh, J.E Cillo, A. Al Sayyari.
Humoral rejection: What the pathologist needs to know Humoral rejection: What the pathologist needs to know Heinz Regele Heinz Regele Clinical Institute.
Pathology of Kidney and the Urinary tract Dr. Amar C. Al-Rikabi Dr. Hala Kasouf Kfouri.
Practical Statistics Regression. There are six statistics that will answer 90% of all questions! 1. Descriptive 2. Chi-square 3. Z-tests 4. Comparison.
Prognostic significance of C4-positive vs. negative rejection Heinz Regele Heinz Regele Department of Pathology Innsbruck Medical University Heinz Regele.
Immunophenotyping Intimal Arteritis Anthony Chang, MD University of Chicago Medical Center.
C4d in pancreas transplant biopsies: the Leiden experience Ingeborg Bajema Ingeborg Bajema Ingeborg Bajema.
Histological markers of CNI nephrotoxicity: Specific or not specific? Marion Rabant MD, Renaud Snanoudj MD, Virginie Royal MD, C. Girardin, E.Morelon MD.
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.
Pathology of Renal Transplantation
The CONVERT Trial Source: Alberú J, Pascoe MD, Campistol JM, et al. Lower malignancy rates in renal allograft recipients converted to sirolimus-based,
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
STUDY OF THE RISK FACTORS OF ACUTE REJECTION AFTER LIVE DONOR RENAL TRANSPLANTATION:A SINGLE EGYPTIAN CENTER EXPERIENCE Ayman M Nagib¹, Ahmed S Elsaied¹,
Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III,
SURVIVAL IN ADULTS UNDERGOING KIDNEY TRANSPLANT FROM CADAVERIC DONORS COMPARED WITH PATIENTS ON WAITING LIST IN ARGENTINA Bisigniano, Liliana.
Kidney Graft Survival Rates do not improve by era: the impact of factor “Age” E. Bertoni MD, A. Larti MD, G. Rosso MD and M. Salvadori MD Renal Unit –
2 Renal Unit, Belfast City Hospital, Belfast, BT9 7AB
Kidney Transplantation and Wait-Listing Rates from the International Dialysis Outcomes and Practice Patterns Study (DOPPS)
Hong Kong Workshop Lecture 8 HLA Epitopes and Acceptable Mismatches for Sensitized Transplant Patients.
Mechanism and Treatment of Antibody-Mediated Rejection
Preservation of Renal Function: The Key to Long-term Kidney Allograft and Patient Survival.
Anand Yuvaraj International Transplant Fellow
Relationship between Mixed Chimerism and Clinical Tolerance after Combined Kidney and Hematopoietic Cell Transplantation using Total Lymphoid Irradiation.
Prognosis of younger patients in non-small cell lung cancer
T. N. Nikonenko, A. V. Trailin and A. S. Nikonenko
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Simple Cysts in Donor Kidney Contribute to Reduced Allograft Function
Figure 2 The association between CD8+ T‑cell density of the tumour
Volume 94, Issue 4, Pages (October 2018)
A Year in Review: Small Bowel/Intestine
Volume 87, Issue 1, Pages (January 2015)
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Figure 1 Faster repopulation of CD19+ cells in patients with a high BSA after treatment with 375 mg/m2 rituximab Faster repopulation of CD19+ cells in.
Patient characteristics: American vs Canadian transplant patients
Volume 56, Issue 5, Pages (November 1999)
Post-transplant membranous glomerulonephritis as a manifestation of chronic antibody-mediated rejection Hyeon Joo Jeong, Beom Jin Lim, Myoung Soo Kima,
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Volume 71, Issue 12, Pages (June 2007)
Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:
Avasare et al. Am J Nephrol 2017;45:99-106  (DOI: / )
Presentation transcript:

The significance of Focal C4d+: The WU experience Helen Liapis, M.D. Professor of Pathology & immunology Kedainis RL et al. Am J Transplant Apr;9(4):812-9.

Patients & Methods Retrospective review of 301 patients (368 biopsies) Inclusion criteria: - indication bx - adequate tissue for evaluation - at least 6 month follow up - DSA test results

Patient demographics Cause of ESRD Therapy (>90% Thymo); CNI (Tacrolimus) antimetabolite and prednisone for maintenance Hx of previous transplantation Donor source HLA match/mismatch Time interval to transplantation Renal function at the time of bx Follow-up period Graft failure (return to dialysis or re-transplt)

Question Focal, diffuse C4d+,C4d- correlation with histopathological findings and graft survival Statistics: Chi-square, ANOVA, Cox regression

C4d+ as defined by BANFF by IF >50% = diffusely % = focal +

C4d results Diffuse C4d+ = 9.5% Focal C4d+ = 20.9% C4d- = 69.4%

p<001

Diffuse C4d+ & PTC 2 PTC 2 = ≥10% with max 5 to 10 luminal inflammatory cells

PTC1 = ≥10% max 3 to 4 luminal inflammatory cells Focal C4d+ and PTC1

Focal C4d+ & TGP: p=0.01 Diffuse +Focal C4d+ =0.02

C4d+ & DSA Variable Diffuse C4d+ (N=29) Focal C4d+ (N=32) C4d- (N=71) DSA+ 23/29 (79.3%)22/32 (68.8%) 7/71 (9.9%) Class I 6 (20.7%) 5 (15.6%) 0 Class II 11 (37.9%) 10 (31.3%) 3 (4.2%) Class I and II 6 (20.7%) 7 (21.9%) 4 (5.7%) 132/301 (43%) had DSA

Cox proportional hazard

Conclusions Focal C4d+ has histopathology similar to diffuse C4d+ Correlation with DSA is similar Focal C4d+ and TGP not significant but there is a trend association Allograft loss: worse prognosis trend at 1 year Overall, focal C4d+ should be taken into account in treatment strategies

Caveats Retrospective study Relatively short follow up DSA only in ~ 50% (44%) C4d- cases were less frequently tested